Search research articles
Contact Us
Filters
Showing results (131-140 of 239) with videos related to
Page
of 24
Sort By:
Human Pathology
|
March 17, 2016
MAGI-2 in prostate cancer: an immunohistochemical study
Jeffery Goldstein, Alexander D Borowsky, Rajen Goyal, et al.
Cancer
|
March 25, 2009
Radical nephrectomy surgical outcomes in the University HealthSystem Consortium Data Base: Impact of hospital case volume, hospital size, and geographic location on 40,000 patients
Robert E Mitchell, Byron T Lee, Michael S Cookson, et al.
The Journal of Urology
|
March 20, 2010
Preoperative hydronephrosis predicts extravesical and node positive disease in patients undergoing cystectomy for bladder cancer
C J Stimson, Michael S Cookson, Daniel A Barocas, et al.
Research and Reports in Urology
|
November 23, 2018
Use of venous-thrombotic-embolic prophylaxis in patients undergoing surgery for renal tumors: a questionnaire survey in the Nordic countries (The NORENCA-2 study)
Lars Lund, Harry Nisen, Petrus Järvinen, et al.
The Journal of Urology
|
December 17, 2008
Comparison of american joint committee on cancer pathological stage T2a versus T2b urothelial carcinoma: analysis of patient outcomes in organ confined bladder cancer
Kelly J Boudreaux, Peter E Clark, William T Lowrance, et al.
World Journal of Urology
|
November 29, 2008
Prognostic factors in T3b renal cell carcinoma
Benjamin J Coons, Andrew A Stec, Kelly L Stratton, et al.
Urologic Oncology
|
May 12, 2024
It's complicated: The relationship of non-narcotic medications and postoperative opioid use in radical cystectomy patients
Samuel J Ivan, Emily H Roebuck, Alexander L Sinks, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 3, 2008
Chemokine markers predict biochemical recurrence of prostate cancer following prostatectomy
David L Blum, Tatsuki Koyama, Amosy E M'Koma, et al.
Plos One
|
August 20, 2011
Serum methionine metabolites are risk factors for metastatic prostate cancer progression
Sally Stabler, Tatsuki Koyama, Zhiguo Zhao, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
February 24, 2021
Claudin-2 inhibits renal clear cell carcinoma progression by inhibiting YAP-activation
Balawant Kumar, Rizwan Ahmad, Giovanna A Giannico, et al.
Page
of 24
Search research articles
Search
Showing results (131-140 of 239) with videos related to
Sort By:
Page
of 24
Human Pathology
|
March 17, 2016
MAGI-2 in prostate cancer: an immunohistochemical study
Jeffery Goldstein, Alexander D Borowsky, Rajen Goyal, et al.
Cancer
|
March 25, 2009
Radical nephrectomy surgical outcomes in the University HealthSystem Consortium Data Base: Impact of hospital case volume, hospital size, and geographic location on 40,000 patients
Robert E Mitchell, Byron T Lee, Michael S Cookson, et al.
The Journal of Urology
|
March 20, 2010
Preoperative hydronephrosis predicts extravesical and node positive disease in patients undergoing cystectomy for bladder cancer
C J Stimson, Michael S Cookson, Daniel A Barocas, et al.
Research and Reports in Urology
|
November 23, 2018
Use of venous-thrombotic-embolic prophylaxis in patients undergoing surgery for renal tumors: a questionnaire survey in the Nordic countries (The NORENCA-2 study)
Lars Lund, Harry Nisen, Petrus Järvinen, et al.
The Journal of Urology
|
December 17, 2008
Comparison of american joint committee on cancer pathological stage T2a versus T2b urothelial carcinoma: analysis of patient outcomes in organ confined bladder cancer
Kelly J Boudreaux, Peter E Clark, William T Lowrance, et al.
World Journal of Urology
|
November 29, 2008
Prognostic factors in T3b renal cell carcinoma
Benjamin J Coons, Andrew A Stec, Kelly L Stratton, et al.
Urologic Oncology
|
May 12, 2024
It's complicated: The relationship of non-narcotic medications and postoperative opioid use in radical cystectomy patients
Samuel J Ivan, Emily H Roebuck, Alexander L Sinks, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 3, 2008
Chemokine markers predict biochemical recurrence of prostate cancer following prostatectomy
David L Blum, Tatsuki Koyama, Amosy E M'Koma, et al.
Plos One
|
August 20, 2011
Serum methionine metabolites are risk factors for metastatic prostate cancer progression
Sally Stabler, Tatsuki Koyama, Zhiguo Zhao, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
February 24, 2021
Claudin-2 inhibits renal clear cell carcinoma progression by inhibiting YAP-activation
Balawant Kumar, Rizwan Ahmad, Giovanna A Giannico, et al.
Page
of 24